| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0047 | 1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |